These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31012882)

  • 1. Intratumoral delivery of M-CSF by calcium crosslinked polymer micelles enhances cancer immunotherapy.
    Mao K; Cong X; Feng L; Chen H; Wang J; Wu C; Liu K; Xiao C; Yang YG; Sun T
    Biomater Sci; 2019 Jun; 7(7):2769-2776. PubMed ID: 31012882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy.
    Wang Y; Luan Z; Zhao C; Bai C; Yang K
    Eur J Pharm Sci; 2020 Jan; 142():105136. PubMed ID: 31704343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart pH-Responsive Nanocube-Controlled Delivery of DNA Vaccine and Chemotherapeutic Drugs for Chemoimmunotherapy.
    Duong HTT; Thambi T; Yin Y; Lee JE; Seo YK; Jeong JH; Lee DS
    ACS Appl Mater Interfaces; 2019 Apr; 11(14):13058-13068. PubMed ID: 30888149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment.
    Xu Z; Wang Y; Zhang L; Huang L
    ACS Nano; 2014 Apr; 8(4):3636-45. PubMed ID: 24580381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Dual-Bioresponsive Drug-Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade.
    Ruan H; Hu Q; Wen D; Chen Q; Chen G; Lu Y; Wang J; Cheng H; Lu W; Gu Z
    Adv Mater; 2019 Apr; 31(17):e1806957. PubMed ID: 30856290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CSF-1R supports T-cell mediated melanoma therapy.
    Sluijter M; van der Sluis TC; van der Velden PA; Versluis M; West BL; van der Burg SH; van Hall T
    PLoS One; 2014; 9(8):e104230. PubMed ID: 25110953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
    Li Y; Lu H; Liang S; Xu S
    ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation.
    Li SY; Liu Y; Xu CF; Shen S; Sun R; Du XJ; Xia JX; Zhu YH; Wang J
    J Control Release; 2016 Jun; 231():17-28. PubMed ID: 26829099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy.
    Ma Z; Hu P; Guo C; Wang D; Zhang X; Chen M; Wang Q; Sun M; Zeng P; Lu F; Sun L; She L; Zhang H; Yao J; Yang F
    Int J Nanomedicine; 2019; 14():5527-5540. PubMed ID: 31413561
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
    Li B; VanRoey M; Wang C; Chen TH; Korman A; Jooss K
    Clin Cancer Res; 2009 Mar; 15(5):1623-34. PubMed ID: 19208793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
    Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
    ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J; Wu JH; Bouganim N; Galipeau J
    Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiated Calcium Carbonate with Enhanced Calcium Overload Induction and Acid Neutralization Capabilities to Boost Chemoimmunotherapy against Liver Cancer.
    Zheng L; Ding Y; Fang S; Yang W; Chen J; Ma J; Wang M; Wang J; Zhang F; Guo X; Zhang K; Shu GF; Weng Q; Wu F; Zhao Z; Chen M; Jiansong J
    ACS Nano; 2024 Oct; 18(40):27597-27616. PubMed ID: 39342637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.
    Kong M; Tang J; Qiao Q; Wu T; Qi Y; Tan S; Gao X; Zhang Z
    Theranostics; 2017; 7(13):3276-3292. PubMed ID: 28900509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced nanoparticle accumulation by tumor-acidity-activatable release of sildenafil to induce vasodilation.
    Zhang P; Zhang Y; Ding X; Xiao C; Chen X
    Biomater Sci; 2020 Jun; 8(11):3052-3062. PubMed ID: 32347852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
    Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
    Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fusion protein and DC vaccine in inhibition of mouse B16F10 melanoma tumor.
    Zhang Y; Liu X; Wang R; Liu S; Wang Y; Jing L; Louis MDJ; Cao R
    Biomed Pharmacother; 2018 Jan; 97():784-792. PubMed ID: 29112931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers.
    Min KH; Min HS; Lee HJ; Park DJ; Yhee JY; Kim K; Kwon IC; Jeong SY; Silvestre OF; Chen X; Hwang YS; Kim EC; Lee SC
    ACS Nano; 2015 Jan; 9(1):134-45. PubMed ID: 25559896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.